On May 5, 2022, 20 members of the EPFL Research Office visited the CIBM MRI EPFL Animal Imaging and Technology Section in Lausanne to learn about the research activities and discover the expertise and infrastructure available to the biomedical imaging community in the Lemanic region.

The visit began with a warm welcome by the CIBM Executive Director, Dr. Pina Marziliano who shared the history of CIBM’s development over the first 15 years of its activity (see video) and an overview of the new organisational structure together with its strategic objectives. “We are in the second phase of development and look forward to fruitful research collaborations with Swiss and international partners,” said Dr. Marziliano concluding her presentation.

The members of the EPFL ReO team were then split into three groups to visit the various infrastructure available in the CIBM MRI EPFL Animal Imaging and Technology Section. The CIBM researchers, operational managers and technicians delivered insightful presentations on the different research problems and on the service they provide to the other researchers by demonstrating the use of the different equipment available at the EPFL. As such, Bernard Lanz and Mario Lepore introduced the Preclinical  9.4T and 14.1T  MRI, Sandra Da Costa and Lijing Xin covered the Human 7T  MRI, Daniel Wenz and Yves Pilloud presented the Radio-Frequency Lab while Katarzyna Pierzchala introduced the Neuro Chemistry Lab. The participants were highly engaged and appreciative of the learnings through the interactive nature of the visit.

As Switzerland lifted all of its pandemic-related restrictions, the CIBM MRI EPFL  team is excited to be able to resume in-person visits to its labs. We look forward to upcoming on-site activities, including the UNIL bachelor students’ visit planned for May 30, 2022.

About EPFL Research Office

The EPFL Research Office supports the EPFL research community by monitoring funding opportunities, providing support in the application process and contracting for public and not-for-profit funding, offering support in the management of large research and mobility projects, and taking charge of ethical aspects linked to research projects.

Comments are closed.